These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33972378)

  • 41. The effect of the length of a malarial epitope on its antigenicity and immunogenicity in an epitope presentation system using the Pseudomonas aeruginosa outer membrane protein OprF as the carrier.
    Wong RS; Hancock RE
    FEMS Microbiol Lett; 1996 Jul; 140(2-3):209-14. PubMed ID: 8764483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential of protein OprF of Pseudomonas in bivalent vaccines.
    Hancock RE; Wong R
    Behring Inst Mitt; 1997 Feb; (98):283-90. PubMed ID: 9382752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific association of lectin LecB with the surface of Pseudomonas aeruginosa: role of outer membrane protein OprF.
    Funken H; Bartels KM; Wilhelm S; Brocker M; Bott M; Bains M; Hancock RE; Rosenau F; Jaeger KE
    PLoS One; 2012; 7(10):e46857. PubMed ID: 23056489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conservation of the gene for outer membrane protein OprF in the family Pseudomonadaceae: sequence of the Pseudomonas syringae oprF gene.
    Ullstrom CA; Siehnel R; Woodruff W; Steinbach S; Hancock RE
    J Bacteriol; 1991 Jan; 173(2):768-75. PubMed ID: 1898935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.
    von Specht BU; Knapp B; Muth G; Bröker M; Hungerer KD; Diehl KD; Massarrat K; Seemann A; Domdey H
    Infect Immun; 1995 May; 63(5):1855-62. PubMed ID: 7729895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of
    Bukhari SI; Aleanizy FS
    Saudi Pharm J; 2020 Feb; 28(2):196-200. PubMed ID: 32042258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pseudomonas aeruginosa porin OprF: properties of the channel.
    Nestorovich EM; Sugawara E; Nikaido H; Bezrukov SM
    J Biol Chem; 2006 Jun; 281(24):16230-7. PubMed ID: 16617058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epitope mapping of the Pseudomonas aeruginosa major outer membrane porin protein OprF.
    Rawling EG; Martin NL; Hancock RE
    Infect Immun; 1995 Jan; 63(1):38-42. PubMed ID: 7806382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the Pseudomonas aeruginosa major outer membrane protein OprF by use of truncated OprF derivatives and monoclonal antibodies.
    Finnen RL; Martin NL; Siehnel RJ; Woodruff WA; Rosok M; Hancock RE
    J Bacteriol; 1992 Aug; 174(15):4977-85. PubMed ID: 1378429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudomonas aeruginosa porin OprF exists in two different conformations.
    Sugawara E; Nestorovich EM; Bezrukov SM; Nikaido H
    J Biol Chem; 2006 Jun; 281(24):16220-9. PubMed ID: 16595653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of AmpD, OprF and penicillin-binding proteins in beta-lactam resistance in clinical isolates of Pseudomonas aeruginosa.
    Bratu S; Landman D; Gupta J; Quale J
    J Med Microbiol; 2007 Jun; 56(Pt 6):809-814. PubMed ID: 17510267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicilin, kanamycin, and tetracycline resistance.
    Peng X; Xu C; Ren H; Lin X; Wu L; Wang S
    J Proteome Res; 2005; 4(6):2257-65. PubMed ID: 16335974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression and testing of Pseudomonas aeruginosa vaccine candidate proteins prepared with the Caulobacter crescentus S-layer protein expression system.
    Umelo-Njaka E; Nomellini JF; Bingle WH; Glasier LG; Irvin RT; Smit J
    Vaccine; 2001 Jan; 19(11-12):1406-15. PubMed ID: 11163663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
    Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biogenesis and functions of model integral outer membrane proteins: Escherichia coli OmpA and Pseudomonas aeruginosa OprF.
    Reusch RN
    FEBS J; 2012 Mar; 279(6):893. PubMed ID: 22248190
    [No Abstract]   [Full Text] [Related]  

  • 57. Novel cationic peptide TP359 down-regulates the expression of outer membrane biogenesis genes in Pseudomonas aeruginosa: a potential TP359 anti-microbial mechanism.
    Dosunmu EF; Chaudhari AA; Bawage S; Bakeer MK; Owen DR; Singh SR; Dennis VA; Pillai SR
    BMC Microbiol; 2016 Aug; 16(1):192. PubMed ID: 27549081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A P5 peptide that is homologous to peptide 10 of OprF from Pseudomonas aeruginosa enhances clearance of nontypeable Haemophilus influenzae from acutely infected rat lung in the absence of detectable peptide-specific antibody.
    Webb DC; Cripps AW
    Infect Immun; 2000 Jan; 68(1):377-81. PubMed ID: 10603411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.
    Arnold H; Bumann D; Felies M; Gewecke B; Sörensen M; Gessner JE; Freihorst J; von Specht BU; Baumann U
    Infect Immun; 2004 Nov; 72(11):6546-53. PubMed ID: 15501786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and Evaluation of a Self-Adjuvanting Pseudomonal Vaccine Based on Major Outer Membrane Porin OprF Epitopes Formulated with Low-Toxicity QS-21-Containing Liposomes.
    Thanvi R; Nada S; Dissanayake R; Vartak A; Sebilleau CO; Alom NE; Prestwich EG; Wall KA; Sucheck SJ
    Bioconjug Chem; 2023 May; 34(5):893-910. PubMed ID: 37092892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.